I had a quick look at this company and I think its too risky to buy. The reasons:
Treating ovarian cancer - survival rate low (diagnosis late), time on treatment is potentially short and I read that is a 3rd line of treatment.
All this adds up to me to be potentially a low income generating stock. Opinions please.
see what happened to tis today, page-45
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.015(4.55%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.0¢ | $1.029M | 3.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 51296 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |